Development methodologies combine old and new techniques, but getting any new material into high-volume manufacturing is a ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

EMD Serono Inc., Merck KGaA’s North American drug development business, has officially taken up residence in Boston’s Seaport ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

Jeanne Penn has been appointed as Vice President, US Commercial for Solici, the strategic competitive intelligence division ...

MilliporeSigma is partnering with the Emmy® and Golden Globe® Award-winning ABC series “Abbott Elementary” to increase access ...

Merck, a leading science and technology company, launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs). ADCs are a rapidly emerging class of ...

The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate ...

Ivonescimab -- a novel first-in-class PD-1/VEGF bispecific antibody -- led to clinically meaningful improvement in progression-free survival (PFS) compared with pembrolizumab (Keytruda) as first-line ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...